Ixekizumab beats ustekinumab for fingernail psoriasis, hands downJanuary 18, 2018PsoriasisPsoriatic Arthritis
Mood changes reported in cases of methotrexate use for dermatologic diseaseJanuary 17, 2018PediatricsPsoriasis
Prior biologic exposure doesn’t diminish ixekizumab’s efficacyJanuary 8, 2018PsoriasisPsoriatic Arthritis
Guselkumab crushes skin disease in psoriatic arthritis patientsDecember 15, 2017Psoriatic ArthritisPsoriasis
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indicationsDecember 14, 2017PsoriasisPsoriatic Arthritis
Interleukin-23 inhibition for psoriasis shows ‘wow’ factorDecember 11, 2017PsoriasisPsoriatic Arthritis
FDA approves IL-17A antagonist for treating psoriatic arthritisDecember 2, 2017Psoriatic ArthritisPsoriasis
Topical tapinarof heads for phase 3 in atopic dermatitis and psoriasisNovember 11, 2017PsoriasisPsoriatic ArthritisAtopic Dermatitis
Ustekinumab may reduce risk of nonmelanoma skin cancerNovember 7, 2017PsoriasisPsoriatic ArthritisNonmelanoma Skin Cancer
Moderate psoriasis: the new frontier for systemic therapiesNovember 6, 2017Psoriatic ArthritisPsoriasis
Guselkumab tops adalimumab for psychiatric comorbidities in psoriasisOctober 31, 2017PsoriasisPsoriatic Arthritis
Psoriasis patients face higher risk of alcohol-related death – but lower suicide riskOctober 27, 2017PsoriasisPsoriatic Arthritis
